NSEAnalysts/Institutional Investor Meet/Con. Call Updates10 Aug 2026 · 10 Aug 2026, 02:41 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Eris Lifesciences Limited · ERIS

✦ AI Summary

Eris Lifesciences Limited has informed the Exchange about the schedule of an analyst/institutional investor meet/conference call on August 14, 2026, where the company's management will discuss publicly available documents and no unpublished price-sensitive information will be disclosed.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Eris Lifesciences Limited has informed the Exchange about Schedule of meet

Attachments (1)

📄

ERIS_10082026144046_intimationsigned.pdf

pdf

Download →
View document text
Date: 10 August 2026 To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Bandra Kurla Complex Mumbai – 400001 Bandra (E) Mumbai – 400051 Security Code: 540596 Symbol: ERIS SUBJECT: INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that the Management of Eris Lifesciences Limited will be participating in the following Investor Conferences: Management Day and Date Fund Name Mode of Meeting Meeting Details Representatives Mr. Amit Bakshi Friday, 11:00 AM IST, Franklin Templeton Virtual Aug 14, 2026 Mr. Krishnakumar 1X1 Vaidyanathan The above schedule is indicative and is subject to changes necessitated by any unforeseen developments. The company will be referring to publicly available documents for discussions during interaction in the meeting and no unpublished price sensitive information (UPSI) is intended to be discussed during the interaction. Thanking You, For Eris Lifesciences Limited Milind Talegaonkar Company Secretary & Compliance Officer Membership No: A26493